The Platform Technology Designation, which precedes the current FDA leadership, is designed to streamline the drug ...

Rui Tostoes, Chief Technology Officer at ImmuneBridge, shares how his team is redefining preclinical development and ...

Researchers from The University of Osaka find that mass photometry can distinguish between full and empty rAAV particles, ...

Cell and gene therapy (C&GT) is set to revolutionise treatment of complex diseases, offering new possibilities for patients.

A team of scientists from the San Raffaele-Telethon Institute for Gene Therapy (SR-Tiget) in Milan, Italy, has identified a ...